dosage of blood biomarker miR1 clinical trials

Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies

This study looks at a tiny molecule called miR-1 in blood to see if it can help doctors understand and track muscle diseases like Duchenne muscular dystrophy. We want to find out if changes in miR-1 levels show how the disease is progressing.